1,018 results on '"Rawlinson, William D."'
Search Results
2. Continued improvement in the development of the SARS-CoV-2 whole genome sequencing proficiency testing program
3. Evidence supporting the use of therapeutic drug monitoring of ganciclovir in transplantation
4. Human cytomegalovirus (CMV) dysregulates neurodevelopmental pathways in cerebral organoids
5. Vaccine value profile for cytomegalovirus
6. Cytomegalovirus cyclin-dependent kinase ortholog vCDK/pUL97 undergoes regulatory interaction with human cyclin H and CDK7 to codetermine viral replication efficiency
7. Human Cytomegalovirus Dysregulates Cellular Dual-Specificity Tyrosine Phosphorylation-Regulated Kinases and Sonic Hedgehog Pathway Proteins in Neural Astrocyte and Placental Models
8. Enteroviruses and risk of islet autoimmunity or type 1 diabetes: systematic review and meta-analysis of controlled observational studies detecting viral nucleic acids and proteins
9. Platform for isolation and characterization of SARS-CoV-2 variants enables rapid characterization of Omicron in Australia
10. External Quality Assessment (EQA) for SARS-CoV-2 RNA Point-of-Care Testing in Primary Healthcare Services: Analytical Performance over Seven EQA Cycles
11. Simultaneous monitoring of eight human respiratory viruses including SARS-CoV-2 using liquid chromatography-tandem mass spectrometry
12. Circulation of enterovirus D68 (EV-D68) causing respiratory illness in New South Wales, Australia, between August 2018 and November 2019
13. Proficiency testing for SARS-CoV-2 whole genome sequencing
14. Proficiency testing for SARS-CoV-2 in assuring the quality and overall performance in viral RNA detection in clinical and public health laboratories
15. Women with type 1 diabetes exhibit a progressive increase in gut Saccharomyces cerevisiae in pregnancy associated with evidence of gut inflammation
16. Proficiency testing for bacterial whole genome sequencing in assuring the quality of microbiology diagnostics in clinical and public health laboratories
17. Estimates of congenital cytomegalovirus‐attributable infant mortality in high‐income countries: A review
18. Virus isolation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) for diagnostic and research purposes
19. Laboratory biosafety measures involving SARS-CoV-2 and the classification as a Risk Group 3 biological agent
20. A quantitative nuclear egress assay to investigate the nucleocytoplasmic capsid release of human cytomegalovirus
21. Respiratory viral co-infections among SARS-CoV-2 cases confirmed by virome capture sequencing
22. Next generation sequencing of human enterovirus strains from an outbreak of enterovirus A71 shows applicability to outbreak investigations
23. Bioinformatic investigation of discordant sequence data for SARS-CoV-2: insights for robust genomic analysis during pandemic surveillance
24. Long-term serial passaging of SARS-CoV-2 reveals signatures of convergent evolution
25. SARS-CoV-2 infection of the placenta is associated with extensive fibrin deposition which may cause adverse pregnancy outcomes
26. Characteristics and Donation Outcomes of Potential Organ Donors Perceived to Be at Increased Risk for Blood-borne Virus Transmission: An Australian Cohort Study 2010–2018
27. Serological testing for infectious diseases markers of donor specimens from 24 h after death show no significant change in outcomes from other specimens
28. Early-life factors contributing to type 1 diabetes
29. SARS-CoV-2 infection of the placenta is associated with extensive fibrin deposition which may cause adverse pregnancy outcomes
30. Recognition, treatment, and sequelae of congenital cytomegalovirus in Australia: An observational study
31. Genome characterization of influenza A and B viruses in New South Wales, Australia, in 2019: A retrospective study using high‐throughput whole genome sequencing.
32. Protocol for a nested case-control study design for omics investigations in the Environmental Determinants of Islet Autoimmunity cohort.
33. Neonates with congenital Cytomegalovirus and hearing loss identified via the universal newborn hearing screening program
34. Analytical validity of nanopore sequencing for rapid SARS-CoV-2 genome analysis
35. Correction to “Machine Learning Color Feature Analysis of a High Throughput Nanoparticle Conjugate Sensing Assay
36. Machine Learning Color Feature Analysis of a High Throughput Nanoparticle Conjugate Sensing Assay
37. Emergence and antibody evasion of BQ, BA.2.75 and SARS-CoV-2 recombinant sub-lineages in the face of maturing antibody breadth at the population level
38. Supplementary Figure Legend from Mouse Mammary Tumor Virus–like Sequences in Human Breast Cancer
39. Supplementary Figure 1 from Mouse Mammary Tumor Virus–like Sequences in Human Breast Cancer
40. Obituary: Peter William Robertson (7 July 1945–6 July 2022)
41. NEW BLOOD BORNE VIRUS INFECTIONS AMONG ORGAN TRANSPLANT RECIPIENTS: A DATA-LINKED COHORT STUDY EXAMINING TRANSMITTED AND DE NOVO HEPATITIS B, C AND HIV INFECTIONS
42. VACCINE-PREVENTABLE INFECTIONS AMONG SOLID ORGAN TRANSPLANT RECIPIENTS: A DATA-LINKED COHORT STUDY, AUSTRALIA, 2000-2015
43. MicroRNAs: A Link Between Type 1 Diabetes and the Environment?
44. Congenital cytomegalovirus infection in pregnancy and the neonate: consensus recommendations for prevention, diagnosis, and therapy
45. Differential Expression of PDGF Receptor-α in Human Placental Trophoblasts Leads to Different Entry Pathways by Human Cytomegalovirus Strains
46. SARS-CoV-2 neutralizing antibodies: Longevity, breadth, and evasion by emerging viral variants
47. A surge in serum mucosal cytokines associated with seroconversion in children at risk for type 1 diabetes.
48. Respiratory infections and type 1 diabetes: Potential roles in pathogenesis
49. Persistence of a Frameshifting Deletion in SARS-CoV-2 ORF7a for the Duration of a Major Outbreak
50. Emergence and antibody evasion of BQ, BA.2.75 and SARS-CoV-2 recombinant sublineages in the face of maturing antibody breadth at the population level
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.